While that study did not report runaway tumor growth either, the lack of a spectacular reduction in tumor size, suggests BPC-157 offers no anti-cancer benefit and it leaves open the worry that it could even accelerate malignancy under the right conditions
Research-grade BPC-157 is legal to purchase for laboratory and investigational research in the United States
If you are unsure about taking gabapentin with hydrocodone or need a second opinion on your treatment plan, Doctronic can help
Before considering BPC-157, speak with a qualified provider who can review your medical history, symptoms, medications, treatment goals, and whether peptide therapy is appropriate for you
Thats about 4.3 weeks of daily loading, or 1015 weeks at maintenance frequency
The mechanism difference matters here